The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
Open accessAbstract
Familial Danish dementia (FDD), also known as heredopathia ophthalmo-oto-encephalica, is an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia. Neuropathological findings include severe widespread cerebral amyloid angiopathy, hippocampal plaques, and neurofibrillary tangles, similar to Alzheimer's disease. N-terminal sequence analysis of isolated leptomeningeal amyloid fibrils revealed homology to ABri, the peptide originated by a point mutation at the stop codon of gene BRI in familial British dementia. Molecular genetic analysis of the BRI gene in the Danish kindred showed a different defect, namely the presence of a 10-nt duplication (795–796insTTTAATTTGT) between codons 265 and 266, one codon before the normal stop codon 267. The decamer duplication mutation produces a frame-shift in the BRI sequence generating a larger-than-normal precursor protein, of which the amyloid subunit (designated ADan) comprises the last 34 C-terminal amino acids. This de novo- created amyloidogenic peptide, associated with a genetic defect in the Danish kindred, stresses the importance of amyloid formation as a causative factor in neurodegeneration and dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disease-causing mutations result in the production of C-terminally extended 277 aa mutant BRI2 proteins, which are cleaved at the normal furin processing site to generate distinct 34 aa peptides (ABri in FBD and ADan in FDD) that accumulate in the brains of affected patients (Vidal et al., 1999(Vidal et al., , 2000)).”
From BRI2 (ITM2b) Inhibits A Deposition In Vivo (2008) · cites this paper as Vidal et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of clinical neuropsychology
Filskov, S. B., & Boll, T. J. (1981) · Wiley eBooks · Cited by 777
Handbook of Clinical Neurology
Dinapoli, R. P. (1972) · Neurology · doi:10.1212/wnl.22.4.394 · Cited by 581
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466
Self-citationProteolytic Processing in the Secretory Pathway
Zhou, A., Webb, G. C., Zhu, X., & Steiner, D. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20745 · Cited by 460
Crook, R., Verkkoniemi, A., Pérez‐Tur, J., Mehta, N. D., Baker, M. C., Houlden, H., Farrer, M. J., Hutton, M., Lincoln, S., Hardy, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-452 · Cited by 356
Ghetti, B. F., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C. E., Frangione, B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.744 · Cited by 281
Self-citationExploring the Etiology of Alzheimer Disease Using Molecular Genetics
Lendon, C. L. (1997) · JAMA · doi:10.1001/jama.1997.03540340059034 · Cited by 274
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154
Transthyretin amyloidosis: A new mutation associated with dementia
Petersen, R. B., Goren, H., Cohen, M. L., Richardson, S. L., Tresser, N. J., Lynn, A., Gali, M., Estes, M. L., & Gambetti, P. L. (1997) · Annals of Neurology · doi:10.1002/ana.410410305 · Cited by 141
FAMILIAL CEREBRAL AMYLOID ANGIOPATHY WITH NONNEURITIC AMYLOID PLAQUE FORMATION
Plant, G. T., Révész, T., Barnard, R. O., Harding, A. E., & Gautier-Smith, P. C. (1990) · Brain · doi:10.1093/brain/113.3.721 · Cited by 132
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- E Strömgrem, A Dalby, M Dalby, B Ranheim Acta Neurol Scand 46,(Suppl. 43), 97–98 (1970).
- R Vidal, F Garzuly, H Budka, M Lalowski, R Linke, F Brittig, B Frangione, T Wisniewski Am J Pathol 148, 361–366 (1996).
Cited by
Sorted by citations
Items 101–200 of 300
Amyloids: from pathogenesis to function
Nizhnikov, A. A., Antonets, K. S., & Inge-Vechtomov, S. G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915090047 · Cited by 53
Modeling familial British and Danish dementia
Garringer, H. J., Murrell, J. R., D'adamio, L., Ghetti, B. F., & Vidal, R. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0221-9 · Cited by 46
Self-citationThe chaperone domain BRICHOS prevents amyloid β-peptide CNS toxicity in Drosophila melanogaster
Hermansson, E., Schultz, S. W., Crowther, D. C., Linse, S. S., Winblad, B. G., Westermark, G. T., Johansson, J., & Presto, J. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014787 · Cited by 48
de Tullio, M. B., Castelletto, V., Hamley, I. W., Adami, P. V. M., Morelli, L., & Castaño, E. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059113 · Cited by 51
Yasukawa, T., Tsutsui, A., Tomomori‐Sato, C., Sato, S., Saraf, A., Washburn, M. P., Florens, L. A., Terada, T., Shimizu, K., Conaway, R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.059 · Cited by 43
Genetic architecture of common non-Alzheimer’s disease dementias
Guerreiro, R. J., Gibbons, E., Tábuas‐Pereira, M., Kun‐Rodrigues, C., Cordeiro, G., & Brás, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104946 · Cited by 48
Pardridge, W. M. (2007) · Stroke · doi:10.1161/01.str.0000247887.61831.74 · Cited by 45
Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias
J, G., A, R., Y, T., T, L., M, B.-M., H, B., G, P., J, H., R, L., T, R., et al. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00563.x · Cited by 44
Self-citationThe Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ 42 and Alzheimer Amyloid Plaques
Dolfe, L., Tambaro, S., Tigro, H., del Campo, M., Hoozemans, J. J. M., Wiehager, B., Graff, C., Winblad, B. G., Ankarcrona, M., Kaldmäe, M., et al. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170051 · Cited by 44
CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.
Ghiso, J. A., Tomidokoro, Y., Révész, T., Frangione, B., & Rostagno, A. A. (2010) · PubMed · Cited by 44
Self-citationKilger, E., Bühler, A., Wölfing, H., Kumar, S., Kaeser, S. A., Nagarathinam, A., Walter, J., Jucker, M., & Coomaraswamy, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288373 · Cited by 42
Rat Blood–Brain Barrier Genomics. II
Li, J. Y., Boado, R. J., & Pardridge, W. M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000040944.89393.0f · Cited by 46
The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
Cisternas, P., Taylor, X., & Lasagna‐Reeves, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246319 · Cited by 42
Specific Chaperones and Regulatory Domains in Control of Amyloid Formation
Landreh, M., Rising, A., Presto, J., Jörnvall, H., & Johansson, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.653097 · Cited by 38
Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia
Gibson, G. L., Gunasekera, N., Lee, M., Lelyveld, V. S., El‐Agnaf, O. M. A., Wright, A., & Austen, B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02134.x · Cited by 38
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
Minimal Model of Self-Assembly: Emergence of Diversity and Complexity
Barz, B., & Urbanc, B. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp412819j · Cited by 37
Buxbaum, J. N., & Johansson, J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00119 · Cited by 37
Wickham, L., Benjannet, S., Marcinkiewicz, E., Chrétien, M., & Seidah, N. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02840.x · Cited by 38
Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors
Xu, C., Wang, Y., & Wu, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00325 · Cited by 36
Neurodegeneration Caused by Proteins with an Aberrant Carboxyl-Terminus
Vidal, R., Delisle, M. B., & Ghetti, B. F. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.8.787 · Cited by 35
Self-citationAmyloid and Amyloid-Like Aggregates: Diversity and the Term Crisis
Matiiv, A. B., Trubitsina, N. P., Matveenko, A. G., Barbitoff, Y. A., Zhouravleva, G. A., & Bondarev, S. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920090035 · Cited by 33
Audo, I. S., Bujakowska, K. M., Orhan, E., Shamieh, S. E., Sennlaub, F., Guillonneau, X., Antonio, A., Michiels, C., Lancelot, M., Letexier, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt439 · Cited by 35
Cerebral Amyloid Angiopathy in East and West
Chen, Y., Lee, M., & Smith, E. E. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00466.x · Cited by 35
Generation and Initial Characterization of FDD Knock In Mice
Giliberto, L., Matsuda, S., Vidal, R., & D'adamio, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007900 · Cited by 33
Self-citationTai, T.-S., Pai, S., & Ho, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096535 · Cited by 33
Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy
You, Y., Perkins, A., Cisternas, P., Muñoz, B., Taylor, X., You, Y., Garringer, H. J., Oblak, A. L., Atwood, B. K., Vidal, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0680-z · Cited by 33
Self-citationPatel, S., Howard, D., Chowdhury, N., Casey, D., Wellslager, B., Yilmaz, Ö., & French, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.646259 · Cited by 36
Lashley, T., Holton, J. L., Verbeek, M. M., Rostagno, A. A., Bojsen‐Møller, M., David, G., van Horssen, J., Brændgaard, H., Plant, G. T., Frangione, B., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00747.x · Cited by 33
Self-citationIncreased AβPP Processing in Familial Danish Dementia Patients
Matsuda, S., Tamayev, R., & D'adamio, L. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110785 · Cited by 31
Lombino, F. L., Biundo, F., Tamayev, R., Arancio, O., & D'adamio, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057120 · Cited by 33
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy
Remes, A. M., Finnilä, S., Mononen, H., Tuominen, H. J., Takalo, R., Herva, R., & Majamaa, K. (2004) · Neurology · doi:10.1212/01.wnl.0000129988.68657.fa · Cited by 32
Lashley, T., Révész, T., Plant, G. T., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., de Silva, R., Ghiso, J. A., Rostagno, A. A., et al. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00935.x · Cited by 31
Self-citationBri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis
Harris, V., Diamanduros, A., Good, P., Zakin, E., Chalivendra, V., & Sadiq, S. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.007 · Cited by 30
Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets?
Mentrup, T., Loock, A.-C., Fluhrer, R., & Schröder, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.007 · Cited by 30
A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain
Leppert, A., Poska, H., Landreh, M., Abelein, A., Chen, G., & Johansson, J. (2023) · Protein Science · doi:10.1002/pro.4645 · Cited by 28
Intramembrane proteolysis within lysosomes
Schröder, B., & Säftig, P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.012 · Cited by 28
The role of the integral type II transmembrane protein BRI2 in health and disease
Martins, F., Santos, I., Silva, O. A. B. D. C. E., Tambaro, S., & Rebelo, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03932-5 · Cited by 28
BRI2 as a central protein involved in neurodegeneration
Tsachaki, M., Ghiso, J. A., & Efthimiopoulos, S. (2008) · Biotechnology Journal · doi:10.1002/biot.200800247 · Cited by 29
Self-citationMorelli, L., Llovera, R. E., Alonso, L. G., Frangione, B., Gay, G. D. P., Ghiso, J. A., & Castaño, E. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.020 · Cited by 28
Self-citationYao, W., Yin, T., Tambini, M. D., & D'adamio, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41340-9 · Cited by 28
Gene identification in Alzheimer’s disease
Saunders, A. M. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.239 · Cited by 30
Lagier‐Tourenne, C., Chaigne, D., Gong, J., Flori, J., Mohr, M., Ruh, D., Christmann, D., Flament, J., Mandel, J., Koenig, M., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.11.838 · Cited by 26
Chromosome 13 dementia syndromes as models of neurodegeneration
Ghiso, J. A., Révész, T., Holton, J. L., Rostagno, A. A., Lashley, T., Houlden, H., Gibb, G., Anderton, B. H., Bek, T., Bojsen‐Møller, M., et al. (2001) · Amyloid · doi:10.3109/13506120108993826 · Cited by 26
Self-citationInteraction Between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders
Mandal, A. K., & Mount, D. B. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01323 · Cited by 25
The genetic causes of neurodegenerative diseases
Hardy, J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3115 · Cited by 26
Gauthier, S. A., Sahoo, S., Jung, S. S., & Levy, E. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_18 · Cited by 26
Biverstål, H., Dolfe, L., Hermansson, E., Leppert, A., Reifenrath, M., Winblad, B. G., Presto, J., & Johansson, J. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.04.005 · Cited by 24
Garringer, H. J., Murrell, J. R., Sammeta, N., Gnezda, A., Ghetti, B. F., & Vidal, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056426 · Cited by 24
Self-citationRidha, B. H., & Josephs, K. A. (2006) · The Neurologist · doi:10.1097/01.nrl.0000186798.86255.69 · Cited by 24
Ocular changes in heredo-oto-ophthalmo-encephalopathy
Bek, T. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.11.1298 · Cited by 24
Self-citationPoska, H., Leppert, A., Tigro, H., Zhong, X., Kaldmäe, M., Nilsson, H. E., Hebert, H., Chen, G., & Johansson, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-66718-y · Cited by 23
del Campo, M., & Teunissen, C. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131364 · Cited by 23
Tamayev, R., & D'adamio, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5193-11.2012 · Cited by 23
Todd, K. L., Ghiso, J. A., & Rostagno, A. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.003 · Cited by 22
Self-citationAnesthetic considerations in patients with Alzheimer’s disease
Fernandez, C. R., Fields, A. M., Richards, T. A., & Kaye, A. D. (2003) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(02)00483-x · Cited by 23
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 21
Rostagno, A. A., Lashley, T., Ng, D., Meyerson, J. L., Brændgaard, H., Plant, G. T., Bojsen‐Møller, M., Holton, J. L., Frangione, B., Révész, T., et al. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.050 · Cited by 22
Self-citationCoutelier, M., Stévanin, G., & Brice, A. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7725-4 · Cited by 21
Tamayev, R., Akpan, N., Arancio, O., Troy, C. M., & D'adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-60 · Cited by 21
Yin, T., Yao, W., Lemenze, A. D., & D’Adamio, L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015679 · Cited by 20
BRI2 homodimerizes with the involvement of intermolecular disulfide bonds
Tsachaki, M., Ghiso, J. A., Rostagno, A. A., & Efthimiopoulos, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.004 · Cited by 21
Self-citationSaul, A., Lashley, T., Révész, T., Holton, J. L., Ghiso, J. A., Coomaraswamy, J., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.014 · Cited by 23
Self-citationTsachaki, M., Serlidaki, D., Fetani, A., Zarkou, V., Rozani, I., Ghiso, J. A., & Efthimiopoulos, S. (2011) · Glycobiology · doi:10.1093/glycob/cwr097 · Cited by 20
Self-citationTsachaki, M., Fotinopoulou, A., Slavi, N., Zarkou, V., Ghiso, J. A., & Efthimiopoulos, S. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310050009 · Cited by 21
Self-citationChen, G., Andrade‐Talavera, Y., Zhong, X., Hassan, S., Biverstål, H., Poska, H., Abelein, A., Leppert, A., Kronqvist, N., Rising, A., et al. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00187j · Cited by 20
Marcora, M. S., Fernández-Gamba, A. C., Avendaño, L. A., Rotondaro, C., Podhajcer, O. L., Vidal, R., Morelli, L., Ceriani, M. F., & Castaño, E. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-5 · Cited by 19
Self-citationIntrinsic Disorder in Proteins Associated with Neurodegenerative Diseases
Uversky, V. N. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_2 · Cited by 20
Anatamopathological spectrum of tauopathies
Révész, T., & Holton, J. L. (2003) · Movement Disorders · doi:10.1002/mds.10558 · Cited by 18
Self-citationHierarchy and the mechanism of fibril formation in ADan peptides
Surolia, I., Reddy, G. B., & Sinha, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04072.x · Cited by 18
Dolfe, L., Winblad, B. G., Johansson, J., & Presto, J. (2015) · Biochemical Journal · doi:10.1042/bj20150920 · Cited by 17
Biundo, F., Ishiwari, K., Prete, D. D., & D'adamio, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7389 · Cited by 15
Tambini, M. D., & D'adamio, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-60800-1 · Cited by 16
Aβ Infusion and Related Models of Alzheimer Dementia
Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 19
Pickford, F., Onstead, L., Camacho-Prihar, C., Hardy, J., & McGowan, E. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01356-3 · Cited by 17
BRI2 and BRI3 are functionally distinct phosphoproteins
Martins, F., Rebelo, S., Santos, M., Cotrim, C. Z., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.012 · Cited by 16
Biundo, F., Ishiwari, K., Del Prete, D., & D’Adamio, L. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.10.009 · Cited by 13
Campo, M. D., Stargardt, A., Veerhuis, R., Reits, E. A., & Teunissen, C. E. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.036 · Cited by 16
Characterization of Amyloid Deposits in Neurodegenerative Diseases
Vidal, R., & Ghetti, B. F. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-328-8_16 · Cited by 16
Self-citationYin, T., Yao, W., Norris, K. A., & D’Adamio, L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101089 · Cited by 14
Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer’s and related dementias
Yin, T., Yesiltepe, M., & D’Adamio, L. (2024) · EMBO Reports · doi:10.1038/s44319-024-00077-x · Cited by 15
A Novel ITM2B Mutation Associated with Familial Chinese Dementia
Liu, X., Chen, K., Wang, Y., Huang, Y., Chen, S.-D., Dong, Q., Cui, M., & Yu, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210176 · Cited by 15
BRI2 as an anti-Alzheimer gene
Matsuda, S., & Senda, T. (2018) · Medical Molecular Morphology · doi:10.1007/s00795-018-0191-1 · Cited by 13
Identification and characterization of the BRI2 interactome in the brain
Martins, F., Marafona, A. M., Pereira, C. D., Müller, T., Looße, C., Kolbe, K., Silva, O. A. B. D. C. E., & Rebelo, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21453-3 · Cited by 15
The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
Murray, C. E., Gami‐Patel, P., Gkanatsiou, E., Brinkmalm, G., Portelius, E., Wirths, O., Heywood, W., Blennow, K., Ghiso, J. A., Holton, J. L., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0563-8 · Cited by 15
Self-citationExtracellular chaperone networks and the export of J-domain proteins
Braun, J. E. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102840 · Cited by 15
Choi, S. C., Kim, J., Kim, T. H., Cho, S. Y., Park, S. S., Kim, K. D., & Lee, S. H. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17113-5 · Cited by 14
Control of amyloid assembly by autoregulation
Landreh, M., Johansson, J., Rising, A., Presto, J., & Jörnvall, H. (2012) · Biochemical Journal · doi:10.1042/bj20120919 · Cited by 13
First identification of ITM2B interactome in the human retina
Wohlschlegel, J., Argentini, M., Michiels, C., Letellier, C., Forster, V., Condroyer, C., He, Z., Thuret, G., Zeitz, C., Léger, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96571-6 · Cited by 13
Greenberg, S. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50039-0 · Cited by 13
Truong, D. T., Shriberg, L. D., Smith, S., Chapman, K. L., Scheer-Cohen, A. R., DeMille, M. M. C., Adams, A. K., Nato, A. Q., Wijsman, E. M., Eicher, J. D., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1717-z · Cited by 12
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
Campo, M. D., Oliveira, C. R., Scheper, W., Zwart, R., Korth, C., Müller‐Schiffmann, A., Kostallas, G., Biverstål, H., Presto, J., Johansson, J., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1769-y · Cited by 12
Cantlon, A., Frigerio, C. S., Freir, D. B., Boland, B., Jin, M., & Walsh, D. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.652263 · Cited by 13
Schmuck, B., Chen, G., Pelcman, J., Kronqvist, N., Rising, A., & Johansson, J. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01638-8 · Cited by 12
Rostagno, A. A., & Ghiso, J. A. (2008) · Neurodegenerative Diseases · doi:10.1159/000113694 · Cited by 12
Self-citationKinetic partitioning between aggregation and vesicle permeabilization by modified ADan
Nesgaard, L. W., Vad, B. S., Christiansen, G., & Otzen, D. E. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.09.021 · Cited by 12
Cordonnier, C., & Leys, D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.062 · Cited by 12
BRI3 associates with SCG10 and attenuates NGF-induced neurite outgrowth in PC12 cells
Gong, Y., Wu, J., Qiang, H., Liu, B., Chi, Z., Chen, T., Yin, B., Peng, X., & Yuan, J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.4.287 · Cited by 12
Hedera, P., & Turner, R. S. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(01)00020-2 · Cited by 12
Synthesis of an O -acyl isopeptide by using native chemical ligation in an aqueous solvent system
Kawashima, H., Kuruma, T., Yamashita, M., Sohma, Y., & Akaji, K. (2014) · Journal of Peptide Science · doi:10.1002/psc.2622 · Cited by 11
Metadata
- Authors
- Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., & Frangione, B.
- Affiliations
- Department of Pathology, New York University School of Medicine, New York 10016; Department of Neuropathology, Institute of Neurology, London, WC1N3BG United Kingdom; Departments of Ophthalmology, Neuropathology and Neurology, Århus University Hospital, Århus, DK8000 Denmark; and The National Hospital for Neurology and Neurosurgery, London, WC1N3BG United Kingdom
- Aarhus University (DK)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-04-18
- Volume
- 97
- Issue
- 9
- Pages
- 4920-4925
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18333
- OpenAlex
- W2137091415
- Cited by
- 300
- References
- 18
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 13 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 14 · 2015: 19 · 2014: 11 · 2013: 9 · 2012: 8
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (5r35ag010953-07)
- National Institute on Aging (R37AG005891, R01AG008721, AG-08721, AG10953, AG05891)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- familial Danish dementia, amyloid peptides, Adán, cerebral amyloid angiopathy, frameshift mutation, de novo mutations, neurodegeneration
- MeSH terms
- Amino Acid Sequence, Amyloid, Base Sequence, Dementia, Denmark, Female, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Pedigree, Temporal Lobe, Sequence Alignment, Sequence Homology, Amino Acid, 3' Untranslated Regions, Gene Duplication, White People, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review